Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-17 Purchase | 2023-03-17 5:03 pm | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 6,300 | $7.8623 | $49,532 | 12,800 (Direct) | View |
| 2023-03-09 Purchase | 2023-03-09 5:56 pm | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 6,500 | $7.735 | $50,278 | 6,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Exercise | 2024-01-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 27,000 | $0 | 122,813 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:44 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 9,125 | $1.05 | 122,813 (Direct) | View |
| 2023-08-01 Tax Withholding | 2023-08-03 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 4,437 | $9.81 | 70,663 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 4:24 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 15,575 | $0 | 70,663 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:04 pm | N/A 2033-01-31 | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO | 486,000 | $0 | 486,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-02 5:10 pm | N/A 2032-07-31 | Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and COO | 280,100 | $0 | 280,100 (Direct) | View |
| 2022-03-11 Disposition | 2022-03-11 4:12 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development | 105,200 | $0 | 36,462 (Direct) | View |
| 2022-03-11 Other | 2022-03-11 4:12 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development | 36,462 | $0 | 36,462 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:02 pm | N/A N/A | ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development | 21,462 | $0 | 36,462 (Direct) | View |
| 2021-08-15 Option Award | 2021-08-17 08:30 am | N/A 2028-08-15 | ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development | 120,200 | $0 | 120,200 (Direct) | View |